Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10164213 | 0.86 | LMNA (0.41) | KMT2AMEN1CYP3A4CYP2C9CYP2D6 | |
| SCHEMBL10164216 | 0.84 | KMT2A (0.33) | KMT2AMEN1CYP2D6TSHR | |
| SCHEMBL10164214 | 0.83 | KMT2A (0.34) | KMT2AMEN1CYP2D6TSHR | |
| SCHEMBL10201407 | 0.82 | KMT2A (0.32) | KMT2AMEN1CYP2D6 | |
| SCHEMBL17350835 | 0.80 | MEN1 (0.32) | KMT2AMEN1 | |
| SCHEMBL10164215 | 0.79 | KMT2A (0.31) | KMT2ACYP2D6 | |
| SCHEMBL10164356 | 0.78 | ADH1C (0.32) | KMT2A | |
| SCHEMBL10966621 | 0.77 | KMT2A (0.38) | KMT2AMEN1CYP3A4CYP2C9CYP2D6 | |
| SCHEMBL10968977 | 0.77 | KMT2A (0.38) | KMT2AMEN1CYP3A4CYP2C9CYP2D6 | |
| SCHEMBL10202403 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120083557-A1 | STERICALLY HINDERED AMINE STABILIZERS | BASF SE (DE) | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120083557-A1 | STERICALLY HINDERED AMINE STABILIZERS | AAAS, H1-5, H1-2 | KMT2A 211/4885MEN1 1314/4885CYP3A4 3818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.